LCTX - Lineage Cell Therapeutics, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts5455
Avg. Estimate-0.05-0.05-0.22-0.18
Low Estimate-0.07-0.09-0.63-0.26
High Estimate-0.02-0.03-0.1-0.12
Year Ago EPS-0.320.3-0.33-0.22
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts5455
Avg. Estimate1.03M690k3.31M2.89M
Low Estimate400k100k2.7M400k
High Estimate2.68M1.15M4.96M5.01M
Year Ago Sales758k750k4.99M3.31M
Sales Growth (year/est)35.90%-8.00%-33.60%-12.70%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.07-0.06-0.05-0.05
EPS Actual-0.320.3-0.2-0.11
Difference-0.250.36-0.15-0.06
Surprise %-357.10%600.00%-300.00%-120.00%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.05-0.05-0.22-0.18
7 Days Ago-0.06-0.06-0.12-0.19
30 Days Ago-0.06-0.06-0.12-0.19
60 Days Ago-0.06-0.06-0.13-0.19
90 Days Ago-0.05-0.06-0.07-0.25
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesLCTXIndustrySectorS&P 500
Current Qtr.84.40%N/AN/A0.01
Next Qtr.-116.70%N/AN/A0.06
Current Year33.30%N/AN/A-0.02
Next Year18.20%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A